Elevated homocysteine and C-reactive protein levels independently predict worsening prognosis after stroke in Chinese patients

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 30, Issue 5, 2010, Pages 643-647

  Yan, Jiangtao ^a   Liao, James K ^b   Wang, Daowen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

C reactive protein; homocysteine; inflammation; stroke

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE;

AGED; ARTICLE; ASIAN; BLOOD; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 78649807958     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-010-0557-7     Document Type: Article

References (32)

1. G.J. Hankey J.W. Eikelboom 1999 Homocysteine and vascular disease Lancet 354 9176 407 413 1:CAS:528:DyaK1MXlt1ajur0%3D 10.1016/S0140-6736(98)11058-9 10437885 (Pubitemid 29355767)
2. P. Durand M. Prost N. Loreau, et al. 2001 Impaired homocysteine metabolism and atherothrombotic disease Lab Invest 81 5 645 672 1:CAS:528:DC%2BD3MXkt1Cqtb8%3D 10.1038/labinvest.3780275 11351038
3. K.S. McCully 1969 Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis The Am J of Pathol 56 1 111 128 1:STN:280:DyaF1M3jtVOntA%3D%3D
4. F.M. Faraci S.R. Lentz 2004 Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction Stroke 35 2 345 347 10.1161/01.STR.0000115161. 10646.67 14757874 (Pubitemid 38174401)
5. G.H. Tofler R.B. D'Agostino P.F. Jacques, et al. 2002 Association between increased homocysteine levels and impaired fibrinolytic potential: potential mechanism for cardiovascular risk Thromb Haemost 88 5 799 804 1:CAS:528:DC%2BD38XptleisLY%3D 12428097
6. C. Zhang Y. Cai M.T. Adachi, et al. 2001 Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response J Biol Chem 276 38 35867 35874 1:CAS:528: DC%2BD3MXntFaht7o%3D 10.1074/jbc.M100747200 11447214
7. C.J. Boushey S.A. Beresford G.S. Omenn, et al. 1995 A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes JAMA 274 13 1049 1057 1:CAS:528:DyaK2MXptFWhuro%3D 10.1001/jama.274.13.1049 7563456
8. Homocystein Studies Collaboration. 2002 Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis JAMA 288 16 2015 2022 10.1001/jama.288.16.2015
9. J.W. Eikelboom E. Lonn J. Genest Jr, et al. 1999 Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence Ann Intern Med 131 5 363 375 1:CAS:528:DyaK1MXmt1KqsL4%3D 10475890
10. M. Klerk P. Verhoef R. Clarke, et al. 2002 MTHFR 677CT Polymorphism and risk of coronary heart disease: A meta-analysis JAMA 288 16 2023 2031 1:CAS:528:DC%2BD3sXpsFOqsrw%3D 10.1001/jama.288.16.2023 12387655 (Pubitemid 35204693)
11. D.S. Wald M. Law J.K. Morris 2002 Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis BMJ 325 7374 1202 1206 10.1136/bmj.325.7374.1202 12446535 (Pubitemid 35398783)
12. P. Libby 2002 Inflammation in atherosclerosis Nature 420 6917 868 874 1:CAS:528:DC%2BD38XpsFygtb8%3D 10.1038/nature01323 12490960 (Pubitemid 36019640)
13. G.J. Blake P.M. Ridker 2002 Inflammatory bio-markers and cardiovascular risk prediction J Intern Med 252 4 283 294 1:CAS:528:DC%2BD38XosVWkt7o%3D 10.1046/j.1365-2796.2002.01019.x 12366601 (Pubitemid 35253696)
14. G. Engström B. Hedblad L. Stavenow, et al. 2004 Fatality of future coronary events is related to inflammation-sensitive plasma proteins: A Population-based prospective cohort study Circulation 110 1 27 31 10.1161/01.CIR.0000133277.88655.00 15210605 (Pubitemid 38880130)
15. J. Danesh J.G. Wheeler G.M. Hirschfield, et al. 2004 C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 14 1387 1397 1:CAS:528:DC%2BD2cXivVagsbc%3D 10.1056/NEJMoa032804 15070788 (Pubitemid 38419992)
16. N.S. Rost P.A. Wolf C.S. Kase, et al. 2001 Plasma Concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The framingham study Stroke 32 11 2575 2579 1:CAS:528:DC%2BD3MXptVGqsLo%3D 10.1161/hs1101.098151 11692019
17. P.M. Ridker M. Cushman M.J. Stampfer, et al. 1998 Plasma concentration of c-reactive protein and risk of developing peripheral vascular disease Circulation 97 5 425 428 1:STN:280:DyaK1c7ktVKktQ%3D%3D 9490235
18. P.M. Ridker C.H. Hennekens J.E. Buring, et al. 2000 C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 12 836 843 1:CAS:528:DC%2BD3cXisVensrs%3D 10.1056/NEJM200003233421202 10733371 (Pubitemid 30165206)
19. W. Koenig M. Sund M. Frohlich, et al. 1999 C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the monica (monitoring trends and determinants in cardiovascular disease) augsburg cohort study, 1984 to 1992 Circulation 99 2 237 242 1:STN:280:DyaK1M7htVOhtQ%3D%3D 9892589
20. M.Y. Youssef O.A. Mojiminiyi N.A. Abdella 2007 Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease Transl Res 150 3 158 163 1:CAS:528:DC%2BD2sXhtVSjsrfI 10.1016/j.trsl.2007.02.006 17761368 (Pubitemid 47302968)
21. M.J. Bos M.L. van Goor P.J. Koudstaal, et al. 2005 Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA J Neurol 252 3 332 337 1:CAS:528:DC%2BD2MXktFyrsLg%3D 10.1007/s00415-005-0647-9 15739046 (Pubitemid 40562166)
22. E. Lonn S. Yusuf M.J. Arnold, et al. 2006 Homocysteine lowering with folic acid and B vitamins in vascular disease N Engl J Med 354 15 1567 1577 1:CAS:528:DC%2BD28XjsVKgs7s%3D 10.1056/NEJMoa060900 16531613
23. NORVIT Investigators. 2006 Homocysteine lowering and cardiovascular events after acute myocardial infarction N Engl J Med 354 15 1578 1588 10.1056/NEJMoa055227
24. B. Van Guelpen J. Hultdin I. Johansson, et al. 2005 Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: A Prospective, nested case-referent study of plasma concentrations and dietary intake Stroke 36 7 1426 1431 10.1161/01.STR.0000169934.96354.3a 15933256 (Pubitemid 40967506)
25. J. Shao J. Yan H. Ye, et al. 2003 Plasma homocysteine level associated with microalbuminuria in Chinese people Chin J Internal Med 42 4 283 284
26. G.K. Hansson 2005 Inflammation, Atherosclerosis, and coronary artery disease N Engl J Med 352 16 1685 1695 1:CAS:528:DC%2BD2MXjsFCltrc%3D 10.1056/NEJMra043430 15843671 (Pubitemid 40530235)
27. P.M. Ridker M. Cushman M.J. Stampfer, et al. 1997 Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 14 973 979 1:CAS:528:DyaK2sXisFOrtL0%3D 10.1056/NEJM199704033361401 9077376 (Pubitemid 27152782)
28. J.L. Mega D.A. Morrow C.P. Cannon, et al. 2006 Cholesterol, c-reactive protein, and cerebrovascular events following intensive and moderate statin therapy J Thromb Thrombolysis 22 1 71 76 1:CAS:528:DC%2BD28XlvFahtL4%3D 10.1007/s11239-006-8081-0 16786236 (Pubitemid 43923005)
29. P.M. Ridker C.P. Cannon D. Morrow, et al. 2005 C-reactive protein levels and outcomes after statin therapy N Engl J Med 352 1 20 28 1:CAS:528: DC%2BD2MXis12msA%3D%3D 10.1056/NEJMoa042378 15635109 (Pubitemid 40075677)
30. K.W. Muir C.J. Weir W. Alwan, et al. 1999 C-reactive protein and outcome after ischemic stroke Stroke 30 5 981 985 1:STN:280:DyaK1M3kvVeitQ%3D%3D 10229731
31. M. Di Napoli F. Papa V. Bocola 2001 C-reactive protein in ischemic stroke: An independent prognostic factor Stroke 32 4 917 924 11283392
32. P. Dusitanond J.W. Eikelboom G.J. Hankey, et al. 2005 Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagul-ability in patients with previous transient ischemic attack or stroke: A randomized substudy of the vitatops trial Stroke 36 1 144 146 1:CAS:528:DC%2BD2cXhtVOqsLzL 10.1161/01.STR.0000150494.91762.70 15569860 (Pubitemid 40054191)